Alzheimer disease: Increased orexin level correlates with sleep disruption and cognitive decline in Alzheimer disease

Nature Reviews Neurology

Volumn 10, Issue 12, 2014, Pages 672-

  Malkki, Hemi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN; NEUROPEPTIDE; SIGNAL PEPTIDE;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DISEASE COURSE; HUMAN; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; NOTE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; WAKEFULNESS; CEREBROSPINAL FLUID; FEMALE; MALE;

ALZHEIMER DISEASE; COGNITION DISORDERS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; SLEEP DISORDERS;

EID: 84927176474     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.209     Document Type: Note

References (1)

1. Lin, R. et al. Modulating effects of WT1 on interferon-β-vitamin D association in MS. Acta Neurol. Scand. doi:10.1111/ane.12315